N-Acetyl Semax Amidate

What Is N-Acetyl Semax Amidate?

N-Acetyl Semax Amidate is the most chemically advanced variant in the Semax peptide family — a doubly-protected, synthetic analogue of adrenocorticotropic hormone (ACTH 4-10) that was originally developed in Russia in the 1980s as a neuroprotective and cognitive-enhancing agent. While standard Semax has a well-established evidence base from decades of Russian clinical use, N-Acetyl Semax Amidate takes the foundational compound and optimises it at both ends of the peptide chain for maximum stability, bioavailability, and duration of action.

Also known as NA-Semax Amidate, NA Semax Amidate or simply Semax Amidate. Every batch is independently tested: the Semax Amidate COA (certificate of analysis) for our 30mg batch is available in the Lab Results section on this page and on our Lab Results page. For the standard, non-amidated form, see Semax.

The "N-Acetyl" designation refers to the addition of an acetyl group (CH₃CO-) at the N-terminus of the peptide chain — replacing the free amine group that makes standard Semax susceptible to rapid enzymatic breakdown. The "Amidate" designation refers to C-terminus amidation, which protects the opposite end of the peptide from carboxypeptidase degradation. Together, these two structural modifications produce a compound that is significantly more resistant to enzymatic hydrolysis, crosses the blood-brain barrier more readily due to enhanced lipophilicity, and maintains active concentrations in brain tissue approximately 30 minutes longer than unmodified Semax.

The result is the same powerful BDNF-upregulating, dopaminergic, neuroprotective core — delivered in a form that is both more potent and more durable than its predecessors in the Semax lineage.

"N-terminal acetylation of Semax results in enhanced resistance to hydrolysis by leucine aminopeptidase, with the modified peptide withstanding degradation 30 minutes longer than unmodified Semax in plasma. Increased stability in brain tissue was also observed, potentially indicating prolonged effects." — Magrì et al., Journal of Inorganic Biochemistry (2015)

---

How It Works — Mechanism of Action

1. Enhanced Stability via Dual Terminal Protection Standard Semax is rapidly cleaved by aminopeptidase enzymes at the N-terminus and carboxypeptidase enzymes at the C-terminus. N-Acetyl Semax Amidate blocks both attack sites simultaneously — the acetyl group at the N-terminus renders it resistant to leucine aminopeptidase, while the amide group at the C-terminus prevents carboxypeptidase hydrolysis. The compound survives significantly longer in plasma and brain tissue, translating to more sustained neurological effects from a single dose.

2. Enhanced Blood-Brain Barrier Penetration The acetylated N-terminus increases the lipophilicity (fat-solubility) of the peptide, improving its ability to passively diffuse across the blood-brain barrier's tight junctions. For subcutaneous administration — where the peptide must travel systemically before reaching the CNS — this enhanced BBB permeability is particularly significant and is a primary reason the amidate form is preferred for injectable protocols.

3. BDNF & NGF Upregulation — The Core Nootropic Mechanism Like all Semax variants, N-Acetyl Semax Amidate's defining neurological effect is potent upregulation of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in the hippocampus and prefrontal cortex. BDNF drives neuroplasticity, promotes new synapse formation, consolidates long-term memory, and supports neuronal survival. Studies demonstrate Semax increases BDNF levels by 1.4× and doubles expression of trkB receptors — the primary signalling receptors for BDNF-mediated neuroplasticity.

4. Dopamine & Serotonin Modulation N-Acetyl Semax Amidate modulates dopaminergic and serotonergic neurotransmission — enhancing the sensitivity and efficiency of these pathways rather than flooding them with exogenous agonists. This produces improved motivation, mood stability, mental drive, and sustained focus without the tolerance, dependency, or post-dose crash associated with conventional stimulants.

5. Melanocortin Receptor Activation As an ACTH 4-10 analogue, the compound retains partial melanocortin receptor (MC4R) activity — a receptor family implicated in cognitive processing, attention, and memory consolidation. This contributes to nootropic effects independently of the BDNF pathway.

6. Enkephalinase Inhibition N-Acetyl Semax Amidate inhibits enzymes responsible for breaking down endogenous enkephalins — endorphin-like neuropeptides that modulate mood, pain perception, and anxiety. By extending enkephalin activity, it contributes to the anxiolytic and mood-stabilising effects reported with Semax-class compounds.

7. Neuroprotection via Anti-Inflammatory Pathways The compound downregulates pro-inflammatory cytokines in brain tissue, activates anti-apoptotic (cell-death prevention) signalling in neurons, improves cerebral blood flow, and protects against ischaemic brain damage — the mechanisms underlying Semax's original clinical use in stroke and traumatic brain injury recovery.

"Semax enhances BDNF levels by 1.4 times and doubles expression of trkB receptors, which are vital for brain cell survival and neuroplasticity." — Dolotov et al., Journal of Neurochemistry (2006)

---

Research-Backed Benefits

Superior Cognitive Enhancement

• Improved working memory, learning rate, and information processing speed
• Enhanced long-term memory consolidation via BDNF-driven hippocampal synaptic strengthening
• Improved executive function: planning, cognitive flexibility, strategic thinking, and decision-making
• Greater potency and duration compared to standard Semax due to enhanced stability and BBB penetration
• Preferred by researchers for cognitive enhancement protocols where sustained, reliable effect duration is required

Focus, Attention & Mental Drive

• Sustained concentration without stimulant-associated hyperarousal, jitteriness, or crash
• Reduced cognitive fatigue under prolonged mental effort
• Enhanced dopaminergic and serotonergic drive — improved motivation, goal-directed behaviour, and mental energy
• Clean, functional cognitive enhancement rather than stimulus-dependent alertness

Neuroprotection & Brain Health

• Protection against ischaemic brain injury, stroke, and traumatic brain injury — the established clinical indication for the Semax compound class
• Reduced neuroinflammation via cytokine downregulation
• Anti-apoptotic signalling supports long-term neuronal survival
• Potential support for age-related cognitive decline prevention
• Emerging evidence in neurodegenerative disease models (Alzheimer's, Parkinson's) via BDNF-mediated protection

Mood Stability & Anxiety Reduction

• Improved mood and emotional resilience through dopaminergic and serotonergic modulation
• Enkephalinase inhibition extends natural anxiolytic peptide activity
• Enhanced mental drive and motivation without stimulant dependency or tolerance
• Complementary to Selank for complete cognitive and emotional optimisation

Optic Nerve & Peripheral Neurological Support

• Semax-class compounds are clinically approved in Russia for optic nerve atrophy and glaucoma-related visual decline, demonstrating neurotrophic effects extending beyond the CNS to peripheral nerve tissue

---

Dosing & Administration

Primary Route: Intranasal Spray

Intranasal delivery provides direct CNS access via the olfactory pathway, bypassing the blood-brain barrier. This route is strongly preferred for Semax-class compounds — it provides high CNS bioavailability with a small systemic dose, and the enhanced lipophilicity of the N-Acetyl Amidate form further improves mucosal absorption.

Standard Dose: 100–3000 mcg per administration depending on protocol (typically 200–400 mcg for standard cognitive enhancement) Frequency: Once or twice daily (3–4× daily for clinical/neuroprotective protocols only) Cycle Length: 10–14 days on, 7–14 days off — cycling preserves receptor sensitivity and prevents BDNF pathway downregulation

Available Concentrations:

• 0.1% solution (1 mg/mL): 100 mcg per 0.1 mL spray — standard starting concentration
• 0.2% solution (2 mg/mL): 200 mcg per 0.1 mL spray — moderate-dose cognitive enhancement
• 1% solution (10 mg/mL): 1000 mcg per 0.1 mL spray — high-dose neuroprotective protocols only

Protocol Variations:

Intranasal Administration Tips:

• Administer directly onto the nasal mucosa with head tilted slightly back to prevent drainage into the throat
• Morning and early afternoon dosing preferred — avoid evening administration as the activating effect may interfere with sleep onset
• Effects typically onset within 20–40 minutes; cognitive and mood benefits compound over 5–7 days of consistent use

Route 2: Subcutaneous Injection

Injection Technique:

• Inject subcutaneously into the abdomen (preferred) or outer thigh — pinch the skin and insert at 45°
• Rotate injection sites across cycles to prevent localised irritation
• Allow the reconstituted solution to reach room temperature before injection

Timing

• Morning dosing strongly preferred — the compound's activating/dopaminergic properties can interfere with sleep onset if administered in the afternoon or evening
• Effects typically begin within 30–60 minutes of injection and are sustained for several hours due to the extended half-life of the amidate form
• Cognitive and mood benefits typically compound over 5–7 days of consistent daily administration before reaching peak effect

Cycle Rationale Cycling is strongly recommended to preserve receptor sensitivity and avoid downregulation of BDNF and melanocortin pathways. A 10–14 day on / 7–14 day off structure mirrors clinical Semax protocols and is the standard in research settings. Do not exceed 30 consecutive days at maximum doses (900 mcg–1 mg/day).

Storage

• Lyophilised (unreconstituted): Store at 2–8°C. Stable for up to 24 months when sealed and refrigerated.
• Reconstituted: Refrigerate at 2–8°C. Use within 28 days. Do not freeze reconstituted solution. Keep away from light.

---

Side Effects & Safety

N-Acetyl Semax Amidate shares the excellent safety profile of the Semax compound class, supported by decades of Russian clinical data on the parent compound and an extensive preclinical literature.

Commonly reported (mild and transient):

• Mild injection site irritation — typical of sub-Q peptide administration; rotate sites to minimise
• Mild headache during the first 2–3 days of a cycle — usually resolves without intervention
• Increased energy or mild activation — dose in the morning to avoid sleep interference
• Mild irritability or overstimulation at higher doses — reduce dose if observed

Key safety advantages:

• No addiction or physical dependency — no evidence of withdrawal, craving, or dependence
• No tolerance with cycling — efficacy is maintained across cycles when appropriate off-periods are observed
• No stimulant-class side effects — no cardiovascular elevation, tachycardia, jitteriness, or sympathomimetic effects
• Reversible — all observed effects resolve after cessation

Important safety considerations:

• Bipolar disorder or psychosis — BDNF upregulation and dopaminergic modulation warrant specialist psychiatric supervision in these populations; consult your physician before use
• Serotonergic or dopaminergic medications (MAOIs, SSRIs, antipsychotics) — potential for pharmacodynamic interactions; consult your physician
• Pregnancy and breastfeeding — avoid use; safety profile in these populations is not established
• Children and adolescents — not appropriate for use outside specialist clinical settings
• Immunosuppressed individuals — consult a physician before use

---

Synergy Stacks

The Complete Cognitive Stack: NA Semax Amidate + Selank The gold-standard nootropic peptide pairing in the Russian clinical and research literature. N-Acetyl Semax Amidate drives BDNF-mediated cognitive performance, focus, and memory; Selank provides GABAergic balance, anxiety reduction, and emotional regulation. Together they address cognitive output (Semax) and cognitive environment (Selank) — the full spectrum of mental optimisation with complementary, non-overlapping mechanisms.

"The combined use of Semax and Selank showed additive effects on cognitive performance and behavioural control." — Andreeva et al., Neuroscience and Behavioural Physiology

Neuroplasticity & Recovery: NA Semax Amidate + BPC-157 BPC-157's neurotrophic, anti-inflammatory, and neuroprotective properties complement the BDNF upregulation of the amidate form. A compelling research stack for recovery from traumatic brain injury, post-concussion syndrome, or cognitive impairment from chronic stress, illness, or neuroinflammation.

Cognitive Longevity: NA Semax Amidate + NAD+ + Epitalon NAD+ drives cellular energy metabolism and sirtuin-mediated gene expression; Epitalon regulates neuroendocrine and pineal function and extends telomere integrity; N-Acetyl Semax Amidate drives BDNF-mediated neuroplasticity. A comprehensive cognitive longevity and anti-ageing brain health protocol.

High-Performance Cognitive & Recovery: NA Semax Amidate + CJC-1295 + Ipamorelin GH secretagogues optimise slow-wave sleep quality and overnight cellular repair — the biological foundation on which Semax's daytime BDNF-driven neuroplasticity is built. Morning NA Semax Amidate for cognitive performance; evening CJC-1295 / Ipamorelin for restorative sleep and GH-mediated tissue repair.

---

Disclaimer: N-Acetyl Semax Amidate is supplied strictly for in vitro laboratory and research purposes. It is not approved by the Therapeutic Goods Administration (TGA) for human therapeutic use in Australia. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. All product information is provided for educational and research reference only. This product must not be administered to humans or animals. Consult a qualified medical professional before making any decisions related to health, supplementation, or peptide research.